- 询价
- Miltenyi Biotec
- 德国
- 130-123-978
- 2025年12月09日
- Flow cytometry, Mass cytometry
- human cell line
- human
企业认证
相关产品推荐更多 >
CD172a (SIRPα) Antibody, anti-rat, PE, REAfinity™, 9 µg in 300 µL
询价
CD146 (LSEC) Antibody, anti-mouse, PE, REAdye_lease™, 200 µL
询价
CD7 Antibody, anti-human, PE, 100 tests in 200 µL
询价CD200R3 Antibody, anti-mouse, APC-Vio® 770, REAfinity™, 9 µg in 300 µL
询价CD27 Antibody, anti-human, VioGreen™, 100 tests in 200 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
CD85d (ILT4)
- 亚型：
recombinant human IgG1
- 形态：
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件：
避光，4-8℃
- 克隆性：
REA184
- 标记物：
PE
- 适应物种：
human
- 保质期：
24个月
- 供应商：
Miltenyi biotec
- 宿主：
human cell line
- 应用范围：
Flow cytometry, Mass cytometry
- 浓度：
1:50
- 抗体英文名：
CD85d (ILT4) Antibody, anti-human, REAfinity™
- 抗体名：
CD85d (ILT4) Antibody, anti-human, REAfinity™
- 规格：
30 tests in 60 µL
Identification and enumeration of CD85d (ILT4)+ cells by flow cytometryClone REA184 recognizes CD85d, also known as immunoglobulin-like transcript 4 (ILT4) or leukocyte Ig-like receptor 2 (LIR2). CD85d is an inhibitory immunoreceptor, expressed mainly on myelomonocytic lineage cells. | CD85d has four tandem Ig-like extracellular domains and three immunoreceptor tyrosine-based inhibitory receptor motifs in its cytoplasmic tails, which recruit the tyrosine phosphatase Src homology 2 domain containing phosphatase 1 (SHP-1). It has been shown that CD85d interacts with HLA-A, -B, -G1, and -E molecules as ligands. HLA-G expression is restricted to trophoblasts and thus interaction of CD85d with HLA-G is suggested to inhibit placental leukocytes, contributing to maternal tolerance of the fetal semiallograft. | Additional information: Clone REA184 displays negligible binding to Fc receptors. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Shiroishi, M. et al. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. U.S.A. 100 (15): 8856–8861. | Shiroishi, M. et al. (2006) Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc. Natl. Acad. Sci. U.S.A. 103: 16412–16417. | Ristich, V. et al. (2007) Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. Hum. Immunol. 68 (4): 264–271.
技术资料暂无技术资料 索取技术资料
文献支持
CD85d (ILT4) Antibody, anti-human, PE, REAfinity™, 30 tests in 60 µL
询价
